One of the longstanding challenges in chemical biology has been finding ways to directly observe biological processes at work ...

Recent technological advances have opened new possibilities for the efficient and sustainable synthesis of various valuable ...

A lab-designed molecule developed and extensively studied by scientists with Virginia Tech's Fralin Biomedical Research ...

Gubra is a highly specialized preclinical CRO and biotech company focused on peptide-based drug discovery within metabolic and fibrotic diseases. In this interview, CEO Henrik Blou reflects on Gubra’s ...

Livagen peptide, a short-chain molecule derived from thymic tissues, has garnered attention recently for its intriguing ...

Alongside its expansion into low-scale oligo synthesis, the company has rebranded its custom oligos to better target ...

In research models, B7-33 has been associated with reduced fibrotic markers and improved tissue architecture. These findings ...

Ongoing research aims to delineate its full spectrum of activity, optimal strategies, and the breadth of its implications.

Kahn is a particular fan of the peptides NAD+ and glutathione—which, she says, “work synergistically to help with energy, ...

EnPlusOne Biosciences, Inc., a biotechnology company pioneering enzymatic solutions for RNA manufacturing, will present new data from its proprietary ezRNA™ platform at TIDES USA, the leading ...

Asahi Kasei Bioprocess America (AKBA) and PeptiSystems have announced a strategic, exclusive partnership aimed at delivering ...